机构:[1]Department of Neuroinfection and Neuroimmunology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.首都医科大学附属天坛医院[2]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.首都医科大学附属天坛医院[3]Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.[4]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.神经科系统神经内科首都医科大学宣武医院[5]Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
Beijing Natural Science Foundation,
Grant/Award Number: 7212030 and
7212029; National Key Research and
Development Program of China, Grant/
Award Number: 2019YFC0121202;
National Natural Science Foundation of
China, Grant/Award Number: 82271374
第一作者机构:[1]Department of Neuroinfection and Neuroimmunology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.[2]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构:[1]Department of Neuroinfection and Neuroimmunology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.[2]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.[4]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.[5]Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
推荐引用方式(GB/T 7714):
Yao Mengyuan,Wang Wenjing,Sun Jiali,et al.The landscape of PBMCs in AQP4-IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry[J].CNS NEUROSCIENCE & THERAPEUTICS.2024,30(2):e14608.doi:10.1111/cns.14608.
APA:
Yao Mengyuan,Wang Wenjing,Sun Jiali,Guo Tianshu,Bian Jiangping...&Yin Linlin.(2024).The landscape of PBMCs in AQP4-IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry.CNS NEUROSCIENCE & THERAPEUTICS,30,(2)
MLA:
Yao Mengyuan,et al."The landscape of PBMCs in AQP4-IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry".CNS NEUROSCIENCE & THERAPEUTICS 30..2(2024):e14608